1.
|
Phase: Phase IV, Phase III Type: Treatment Status: Active Age: 21 and under Sponsor: Other Protocol IDs: GPOH-NB2004, EU-20661, NCT00410631
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Active Age: Over 15 Sponsor: Other Protocol IDs: GMALL05, NCT00199082
|
|
3.
|
Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: Any age Sponsor: Other Protocol IDs: UKM08_0057, 2009-018072-33, NCT01424839
|
|
4.
|
Phase: Phase IV Type: Treatment Status: Active Age: 14 to 70 Sponsor: Other Protocol IDs: hnslblzlzx2011, NCT01501136
|
|
5.
|
Phase: Phase IV Type: Treatment Status: Active Age: 14 to 70 Sponsor: Other Protocol IDs: hnslblzlzx2011-2, NCT01501149
|
|
6.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: LMU-DOLPHIN-1, EU-20220, NCT00045461
|
|
7.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 40 and over Sponsor: Other Protocol IDs: ISG/OS-2, 2011-001659-36, NCT01459484
|
|
8.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: CKTO-2000-06, HOVON-44, HOVON-44/CKVO-2000-06, EU-20042, ISRCTN95614846, NCT00012051
|
|
9.
|
Phase: Phase III Type: Treatment Status: Active Age: Under 50 Sponsor: NCI, Other Protocol IDs: CDR0000068608, EURO-EWING-INTERGROUP-EE99, EBMT-INTERGROUP-EE99, EORTC-62981, GPOH-AUSTRIA-INTERGROUP-EE99, GPOH-GERMANY-INTERGROUP-EE99, SFOP-INTERGROUP-EE99, SWS-SAKK-INTERGROUP-EE99, CCLG-INTERGROUP-EE99, COG-AEWS0331, EU-20213, AEWS0331, NCT00020566
|
|
10.
|
Phase: Phase III Type: Treatment Status: Active Age: Over 16 Sponsor: Other Protocol IDs: CDR0000416124, FRE-FNCLCC-GETUG-13/0206, EU-20502, NCT00104676
|
|
11.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: 119 of 2003, NCT00193739
|
|
12.
|
Phase: Phase III Type: Treatment Status: Active Age: Under 21 Sponsor: Other Protocol IDs: CCLG-EPSSG-NRSTS-2005, EU-20620, EUDRACT-2005-001139-31, UKCCSG-CTA-21275/0215/001/0001, CCLG-EpSSG-STS-2006-03, NCT00334854
|
|
13.
|
Phase: Phase III Type: Treatment Status: Active Age: Under 21 Sponsor: Other Protocol IDs: CCLG-EPSSG-RMS-2005, EU-20639, EUDRACT-2005-000217-35, UKCCSG-RMS-2005, NCT00379457
|
|
14.
|
Phase: Phase III Type: Treatment Status: Active Age: 1 to 18 Sponsor: Other Protocol IDs: CDR0000528029, ALL-BFM-2000, EU-20682, NCT00430118
|
|
15.
|
Phase: Phase III Type: Diagnostic, Treatment Status: Active Age: 17 and under Sponsor: Other Protocol IDs: CDR0000531687, EURONET-PHL-C1, EU-20703, EUDRACT-2006-000995-33, CCLG-HD-2007-10, NCT00433459
|
|
16.
|
Phase: Phase III Type: Treatment Status: Active Age: 5 to 50 Sponsor: Other Protocol IDs: CDR0000543987, FRE-FNCLCC-SARCOME-09-0603, FRE-FNCLCC-OS-2006, NOVARTIS-FRE-FNCLCC-SARCOME-09, CHUGAI-FRE-FNCLCC-SARCOME-09-0, EU-20729, EUDRACT-2006-00337727, NOVARTIS-FRE-FNCLCC-SARCOME-09-0603, CHUGAI-FRE-FNCLCC-SARCOME-09-0603, SARCOME 09/0603, NCT00470223
|
|
17.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: SARC-GYN1, NCT00162721
|
|
18.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: DSMM V, NCT00546988
|
|
19.
|
Phase: Phase III Type: Diagnostic, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: PETAL trial, EudraCT-Number 2006-001641-33, Krebshilfe Grant 107592, NCT00554164
|
|
20.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ELCWP 01994, NCT00658580
|
|
21.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and under Sponsor: Other Protocol IDs: CDR0000613220, MOTOL-ALL-IC-BFM-2002, EU-20871, ALL-IC-BFM-2002, NCT00764907
|
|
22.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: CDR0000633503, GOELAMS-LH2007, GOELAMS-ID-RCB#2007-A01079-44, INCA-RECF0754, AMGEN-GOELAMS-LH2007, NCT00920153
|
|
23.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: GOG-0261, GOG-0261, NCT00954174
|
|
24.
|
Phase: Phase III Type: Treatment Status: Active Age: 4 to 50 Sponsor: Other Protocol IDs: 108128, EudraCT number: 2008-003658-13, NCT00987636
|
|
25.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 110928, NCT01014208
|